The largest database of trusted experimental protocols

Rosettesep human mesenchymal stem cell enrichment cocktail

Manufactured by STEMCELL
Sourced in Canada

The RosetteSep Human Mesenchymal Stem Cell Enrichment Cocktail is a cell separation product designed to enrich mesenchymal stem cells from human samples. It is a mixture of antibodies that crosslink unwanted cells to RosetteSep densification medium, allowing the target cells to be isolated by centrifugation.

Automatically generated - may contain errors

5 protocols using rosettesep human mesenchymal stem cell enrichment cocktail

1

Isolation of Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mesenchymal stem cells (MSCs) were isolated from whole blood from five healthy donors (all enrolled in the study after signing on informed consent and post approval from our Institutional Review Board) with RosetteSep Human Mesenchymal Stem Cell Enrichment Cocktail (Stem Cell Technologies, Vancouver, BC, Canada). MSCs were cultured under the same conditions as TDECs.
+ Open protocol
+ Expand
2

Isolation of Bone Marrow-Derived Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
In total, bone marrow samples (60 mL) were aspirated from the iliac crest bone of consenting healthy adult donors (n = 41, median age 25 years, and range 19–35). The study was approved by the local ethics committee. Bone marrow mononuclear cells (BM-MNCs) were isolated by density gradient centrifugation (Ficoll-Paque Premium; GE Healthcare Life Sciences) following incubation with RosetteSep Human Mesenchymal Stem Cell Enrichment Cocktail (StemCell Technologies) for lineage depletion (CD3, CD14, CD19, CD38, CD66b, and glycophorin A).
+ Open protocol
+ Expand
3

Isolation of Bone Marrow-Derived Mononuclear Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow samples were aspirated from the iliac crest of healthy donors (60 ml, n = 21, median age 25, range 18–45). All participants in the study gave a written informed consent. The procedure was approved by the Swedish local ethics committee in Lund (Regionala Etikprövningsnämden Lund, EPN, protocol Dnr2009/532) and all experimental protocols were performed according to EPN’s guidelines. Bone marrow mononuclear cells (BM-MNCs) were isolated by density gradient centrifugation (Ficoll-paque medium, GE Healthcare Life Sciences) combined with prior incubation with RosetteSep Human Mesenchymal Stem Cell Enrichment Cocktail (StemCell Technologies) for lineage depletion (CD3, CD14, CD19, CD38, CD66b and glycophorin A).
+ Open protocol
+ Expand
4

Diverse Cell Lines and Knockdown Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human MSCs (CD105+/CD73+/CD44+ and CD34−/CD45−/CD14−/HLA−DR−; Texas A&M Institute for Regenerative Medicine, Bryan, TX) were maintained in MEMα with 20% FBS; a subset was GFP+. Transduction with MZF1 siRNA generated MSCs with constitutive knockdown of MZF1 (MSC(dMZF1)) for use in animal studies. After IRB approval, primary human MSCs (BM-MSCs) were isolated using RosetteSep Human Mesenchymal Stem Cell Enrichment Cocktail (STEMCELL, Vancouver, Canada) from normal human BM isolates. Human MDA-MB231 and MCF7 breast cancer cell lines, purchased from American Type Culture Collection (ATCC, Manassas, VA), were maintained in DMEM with 10% FBS. Lentiviral transduction (GenTarget Inc, San Diego, CA) was used to generate dual-labeled RFP-Luc-MB231 and RFP-Luc-MCF7 cells for use in animal studies. Further manipulation using lentiviral transduction generated MCF7 cells that constitutively express OPN (RFP-Luc-MCF7-lvOPN). Human skin fibroblasts (CCD-1140SK), human lung fibroblasts (MRC-5), and murine embryonic fibroblasts (CF-1) were purchased from ATCC. Human mammary fibroblasts were a gift from Dr. Kuperwasser, Tufts University.
+ Open protocol
+ Expand
5

Diverse Cell Lines and Knockdown Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human MSCs (CD105+/CD73+/CD44+ and CD34−/CD45−/CD14−/HLA−DR−; Texas A&M Institute for Regenerative Medicine, Bryan, TX) were maintained in MEMα with 20% FBS; a subset was GFP+. Transduction with MZF1 siRNA generated MSCs with constitutive knockdown of MZF1 (MSC(dMZF1)) for use in animal studies. After IRB approval, primary human MSCs (BM-MSCs) were isolated using RosetteSep Human Mesenchymal Stem Cell Enrichment Cocktail (STEMCELL, Vancouver, Canada) from normal human BM isolates. Human MDA-MB231 and MCF7 breast cancer cell lines, purchased from American Type Culture Collection (ATCC, Manassas, VA), were maintained in DMEM with 10% FBS. Lentiviral transduction (GenTarget Inc, San Diego, CA) was used to generate dual-labeled RFP-Luc-MB231 and RFP-Luc-MCF7 cells for use in animal studies. Further manipulation using lentiviral transduction generated MCF7 cells that constitutively express OPN (RFP-Luc-MCF7-lvOPN). Human skin fibroblasts (CCD-1140SK), human lung fibroblasts (MRC-5), and murine embryonic fibroblasts (CF-1) were purchased from ATCC. Human mammary fibroblasts were a gift from Dr. Kuperwasser, Tufts University.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!